Kyongbo Pharmaceutical Co Ltd (214390) — Free Cash Flow Generation Index
Kyongbo Pharmaceutical Co Ltd (214390) has a Free Cash Flow Generation Index of -2.78x as of September 2025. Free cash flow of ₩-12.53 Billion represents -3% of operating cash flow (₩4.51 Billion). See 214390 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Kyongbo Pharmaceutical Co Ltd Free Cash Flow Generation Index (2014–2024)
Historical FCF Generation Index trend for Kyongbo Pharmaceutical Co Ltd across 10 annual periods. Explore 214390 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Kyongbo Pharmaceutical Co Ltd (2014–2024)
Year-by-year Free Cash Flow Generation Index for Kyongbo Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 214390 market cap overview.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -87.35x | ₩-13.03 Billion | ₩149.12 Million | ₩13.18 Billion | ▼ -6914.5% |
| 2023 | -1.25x | ₩-6.03 Billion | ₩4.84 Billion | ₩10.88 Billion | ▼ -312.5% |
| 2022 | -0.30x | ₩-3.06 Billion | ₩10.13 Billion | ₩13.18 Billion | ▼ -1425.3% |
| 2021 | -0.02x | ₩-355.61 Million | ₩17.97 Billion | ₩18.32 Billion | ▼ -104.9% |
| 2020 | 0.40x | ₩8.36 Billion | ₩20.80 Billion | ₩12.44 Billion | ▲ +2154.5% |
| 2019 | 0.02x | ₩421.97 Million | ₩23.67 Billion | ₩23.25 Billion | ▼ -97.5% |
| 2017 | 0.71x | ₩18.41 Billion | ₩25.81 Billion | ₩7.40 Billion | ▲ +220.1% |
| 2016 | 0.22x | ₩5.64 Billion | ₩25.33 Billion | ₩19.68 Billion | ▲ +104.1% |
| 2015 | -5.43x | ₩-23.02 Billion | ₩4.24 Billion | ₩27.26 Billion | ▼ -2589.5% |
| 2014 | -0.20x | ₩-3.24 Billion | ₩16.04 Billion | ₩19.28 Billion | — |